{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:07:59Z","timestamp":1779350879436,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sumitomo Pharma, Japan"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25wm0625323h0001"],"award-info":[{"award-number":["25wm0625323h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bipolar disorder is one of major psychiatric disorders afflicting about 1% of the world population. While genetic factors have been increasingly recognized as contributing to the disorder, the underlying etiology of bipolar disorder, such as associated brain regions and cellular pathology, are yet to be elucidated. Our previous studies using a genetic bipolar disorder animal model indicated potential role of the paraventricular thalamic nucleus (PVT) in recurrent depressive-like episodes that exhibit phenotypic similarity to the depression phase of bipolar disorder. Notably, chronic activation of PVT induced spontaneous depressive-like episodes. Primary projection targets of PVT include the nucleus accumbens (NAc) and basolateral amygdala (BLA). However, the circuit involving PVT that causes recurrent depressive-like episodes remains to be addressed. Thus, we activated the PVT neurons projecting to NAc or BLA selectively to investigate their roles in eliciting depressive-like episodes. We found that activation of the PVT\u2013NAc pathway induced depressive-like episodes, as measured by reduced wheel running activity in mice. In contrast, wheel running activity was unaffected by activation of the PVT\u2013BLA pathway. These results highlight the critical involvement of PVT\u2013NAc circuit in mood regulation and suggest it may be a key neural substrate underlying depressive-like episodes in bipolar disorder.<\/jats:p>","DOI":"10.1038\/s41598-026-45354-y","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:36:05Z","timestamp":1775136965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathway-specific regulation of the paraventricular thalamic nucleus in depressive-like behavior"],"prefix":"10.1038","volume":"16","author":[{"given":"Momoe","family":"Kassai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Miyanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Sakashita-Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadafumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"45354_CR1","doi-asserted-by":"publisher","first-page":"706713","DOI":"10.3389\/fnint.2021.706713","volume":"15","author":"AG Iglesias","year":"2021","unstructured":"Iglesias, A. G. & Flagel, S. B. The paraventricular thalamus as a critical node of motivated behavior via the hypothalamic-thalamic-striatal circuit. Front. Integr. Neurosci. 15, 706713. https:\/\/doi.org\/10.3389\/fnint.2021.706713 (2021).","journal-title":"Front. Integr. Neurosci."},{"key":"45354_CR2","doi-asserted-by":"publisher","first-page":"627633","DOI":"10.3389\/fnbeh.2021.627633","volume":"15","author":"GJ Kirouac","year":"2021","unstructured":"Kirouac, G. J. The paraventricular nucleus of the thalamus as an integrating and relay node in the brain anxiety network. Front. Behav. Neurosci. 15, 627633. https:\/\/doi.org\/10.3389\/fnbeh.2021.627633 (2021).","journal-title":"Front. Behav. Neurosci."},{"key":"45354_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnbeh.2014.00073","volume":"8","author":"DT Hsu","year":"2014","unstructured":"Hsu, D. T., Kirouac, G. J., Zubieta, J. K. & Bhatnagar, S. Contributions of the paraventricular thalamic nucleus in the regulation of stress, motivation, and mood. Front. Behav. Neurosci. 8, 73. https:\/\/doi.org\/10.3389\/fnbeh.2014.00073 (2014).","journal-title":"Front. Behav. Neurosci."},{"key":"45354_CR4","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1111\/ejn.70168","volume":"61","author":"S Seeger-Armbruster","year":"2025","unstructured":"Seeger-Armbruster, S., Wang, M., Campbell, R. E. & Hyland, B. I. Paraventricular nucleus of the thalamus neurons that project to the Nucleus Accumbens show enhanced c-Fos expression during early-stage cue-reward associative learning in male rats. Eur. J. Neurosci. 61, e70168. https:\/\/doi.org\/10.1111\/ejn.70168 (2025).","journal-title":"Eur. J. Neurosci."},{"key":"45354_CR5","doi-asserted-by":"publisher","first-page":"e1543","DOI":"10.1016\/j.cub.2024.02.037","volume":"34","author":"S Beas","year":"2024","unstructured":"Beas, S. et al. Dissociable encoding of motivated behavior by parallel thalamo-striatal projections. Curr. Biol. 34, e1543. https:\/\/doi.org\/10.1016\/j.cub.2024.02.037 (2024).","journal-title":"Curr. Biol."},{"key":"45354_CR6","doi-asserted-by":"publisher","first-page":"673162","DOI":"10.3389\/fnbeh.2021.673162","volume":"15","author":"CL Kooiker","year":"2021","unstructured":"Kooiker, C. L., Birnie, M. T. & Baram, T. Z. The paraventricular thalamus: a potential sensor and integrator of emotionally salient early-life experiences. Front. Behav. Neurosci. 15, 673162. https:\/\/doi.org\/10.3389\/fnbeh.2021.673162 (2021).","journal-title":"Front. Behav. Neurosci."},{"key":"45354_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tins.2021.03.001","volume":"44","author":"MA Penzo","year":"2021","unstructured":"Penzo, M. A. & Gao, C. The paraventricular nucleus of the thalamus: an integrative node underlying homeostatic behavior. Trends Neurosci. 44, 538\u2013549. https:\/\/doi.org\/10.1016\/j.tins.2021.03.001 (2021).","journal-title":"Trends Neurosci."},{"key":"45354_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.phrs.2019.02.014","volume":"142","author":"K Zhou","year":"2019","unstructured":"Zhou, K. & Zhu, Y. The paraventricular thalamic nucleus: a key hub of neural circuits underlying drug addiction. Pharmacol. Res. 142, 70\u201376. https:\/\/doi.org\/10.1016\/j.phrs.2019.02.014 (2019).","journal-title":"Pharmacol. Res."},{"key":"45354_CR9","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1113\/JP282996","volume":"600","author":"C Dumont","year":"2022","unstructured":"Dumont, C., Li, G., Castel, J., Luquet, S. & Gangarossa, G. Hindbrain catecholaminergic inputs to the paraventricular thalamus scale feeding and metabolic efficiency in stress-related contexts. J. Physiol. 600, 2877\u20132895. https:\/\/doi.org\/10.1113\/JP282996 (2022).","journal-title":"J. Physiol."},{"key":"45354_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nature14030","volume":"519","author":"FH Do-Monte","year":"2015","unstructured":"Do-Monte, F. H., Quinones-Laracuente, K. & Quirk, G. J. A temporal shift in the circuits mediating retrieval of fear memory. Nature 519, 460\u2013463. https:\/\/doi.org\/10.1038\/nature14030 (2015).","journal-title":"Nature"},{"key":"45354_CR11","doi-asserted-by":"publisher","first-page":"e1114","DOI":"10.1016\/j.neuron.2020.06.028","volume":"107","author":"PC Keyes","year":"2020","unstructured":"Keyes, P. C. et al. Orchestrating opiate-associated memories in thalamic circuits. Neuron 107, e1114. https:\/\/doi.org\/10.1016\/j.neuron.2020.06.028 (2020).","journal-title":"Neuron"},{"key":"45354_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1126\/science.aat2512","volume":"362","author":"S Ren","year":"2018","unstructured":"Ren, S. et al. The paraventricular thalamus is a critical thalamic area for wakefulness. Science 362, 429\u2013434. https:\/\/doi.org\/10.1126\/science.aat2512 (2018).","journal-title":"Science"},{"key":"45354_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaf034","author":"HB Elam","year":"2025","unstructured":"Elam, H. B. et al. Inhibition of hippocampal or thalamic inputs to the nucleus accumbens reverses stress-induced alterations in dopamine system function. Int. J. Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyaf034 (2025).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"45354_CR14","doi-asserted-by":"publisher","first-page":"e3002962","DOI":"10.1371\/journal.pbio.3002962","volume":"23","author":"A Jasz","year":"2025","unstructured":"Jasz, A. et al. Persistently increased post-stress activity of paraventricular thalamic neurons is essential for the emergence of stress-induced alterations in behaviour. PLoS Biol. 23, e3002962. https:\/\/doi.org\/10.1371\/journal.pbio.3002962 (2025).","journal-title":"PLoS Biol."},{"key":"45354_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0006-3223(97)00012-7","volume":"42","author":"T Kato","year":"1997","unstructured":"Kato, T., Stine, O. C., McMahon, F. J. & Crowe, R. R. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol. Psychiatry 42, 871\u2013875. https:\/\/doi.org\/10.1016\/S0006-3223(97)00012-7 (1997).","journal-title":"Biol. Psychiatry"},{"key":"45354_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1017\/s1092852900015303","volume":"12","author":"O Fattal","year":"2007","unstructured":"Fattal, O., Link, J., Quinn, K., Cohen, B. H. & Franco, K. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 12, 429\u2013438. https:\/\/doi.org\/10.1017\/s1092852900015303 (2007).","journal-title":"CNS Spectr."},{"key":"45354_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-8-9","volume":"8","author":"G Inczedy-Farkas","year":"2012","unstructured":"Inczedy-Farkas, G. et al. Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behav. Brain Funct. 8, 9. https:\/\/doi.org\/10.1186\/1744-9081-8-9 (2012).","journal-title":"Behav. Brain Funct."},{"key":"45354_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10072-011-0901-0","volume":"34","author":"M Mancuso","year":"2013","unstructured":"Mancuso, M. et al. Psychiatric involvement in adult patients with mitochondrial disease. Neurol. Sci. 34, 71\u201374. https:\/\/doi.org\/10.1007\/s10072-011-0901-0 (2013).","journal-title":"Neurol. Sci."},{"key":"45354_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/sj.mp.4001824","volume":"11","author":"T Kasahara","year":"2006","unstructured":"Kasahara, T. et al. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol. Psychiatry 11, 577\u2013593. https:\/\/doi.org\/10.1038\/sj.mp.4001824 (2006).","journal-title":"Mol. Psychiatry"},{"key":"45354_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/mp.2015.156","volume":"21","author":"T Kasahara","year":"2016","unstructured":"Kasahara, T. et al. Depression-like episodes in mice harboring mtDNA deletions in paraventricular thalamus. Mol. Psychiatry 21, 39\u201348. https:\/\/doi.org\/10.1038\/mp.2015.156 (2016).","journal-title":"Mol. Psychiatry"},{"key":"45354_CR21","doi-asserted-by":"publisher","first-page":"16506","DOI":"10.1038\/s41598-019-52984-y","volume":"9","author":"TM Kato","year":"2019","unstructured":"Kato, T. M. et al. Presynaptic dysregulation of the paraventricular thalamic nucleus causes depression-like behavior. Sci. Rep. 9, 16506. https:\/\/doi.org\/10.1038\/s41598-019-52984-y (2019).","journal-title":"Sci. Rep."},{"key":"45354_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1021\/cn500325v","volume":"6","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs. ACS Chem. Neurosci. 6, 476\u2013484. https:\/\/doi.org\/10.1021\/cn500325v (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"45354_CR23","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1038\/s41598-018-22116-z","volume":"8","author":"DF Manvich","year":"2018","unstructured":"Manvich, D. F. et al. The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice. Sci. Rep. 8, 3840. https:\/\/doi.org\/10.1038\/s41598-018-22116-z (2018).","journal-title":"Sci. Rep."},{"key":"45354_CR24","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1038\/s41598-019-41088-2","volume":"9","author":"M Jendryka","year":"2019","unstructured":"Jendryka, M. et al. Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice. Sci. Rep. 9, 4522. https:\/\/doi.org\/10.1038\/s41598-019-41088-2 (2019).","journal-title":"Sci. Rep."},{"key":"45354_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.physbeh.2007.05.015","volume":"92","author":"S Brene","year":"2007","unstructured":"Brene, S. et al. Running is rewarding and antidepressive. Physiol. Behav. 92, 136\u2013140. https:\/\/doi.org\/10.1016\/j.physbeh.2007.05.015 (2007).","journal-title":"Physiol. Behav."},{"key":"45354_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neulet.2003.08.073","volume":"352","author":"H Vargas-Perez","year":"2003","unstructured":"Vargas-Perez, H., Mena-Segovia, J., Giordano, M. & Diaz, J. L. Induction of c-fos in nucleus accumbens in naive male Balb\/c mice after wheel running. Neurosci. Lett. 352, 81\u201384. https:\/\/doi.org\/10.1016\/j.neulet.2003.08.073 (2003).","journal-title":"Neurosci. Lett."},{"key":"45354_CR27","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","volume":"92","author":"DG Tervo","year":"2016","unstructured":"Tervo, D. G. et al. A designer AAV variant permits efficient retrograde access to projection neurons. Neuron 92, 372\u2013382. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.021 (2016).","journal-title":"Neuron"},{"key":"45354_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy183","author":"TE Scammell","year":"2019","unstructured":"Scammell, T. E., Jackson, A. C., Franks, N. P., Wisden, W. & Dauvilliers, Y. Histamine: neural circuits and new medications. Sleep https:\/\/doi.org\/10.1093\/sleep\/zsy183 (2019).","journal-title":"Sleep"},{"key":"45354_CR29","doi-asserted-by":"publisher","first-page":"149226","DOI":"10.1016\/j.brainres.2024.149226","volume":"1846","author":"L Miranda","year":"2025","unstructured":"Miranda, L. Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them\u2014a scoping review of available literature. Brain Res. 1846, 149226. https:\/\/doi.org\/10.1016\/j.brainres.2024.149226 (2025).","journal-title":"Brain Res."},{"key":"45354_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/FBP.0000000000000786","volume":"35","author":"R Patel","year":"2024","unstructured":"Patel, R. & Jain, N. S. Stimulation of central histaminergic transmission attenuates diazepam-induced motor disturbance on rota-rod and beam walking tests in mice. Behav. Pharmacol. 35, 351\u2013365. https:\/\/doi.org\/10.1097\/FBP.0000000000000786 (2024).","journal-title":"Behav. Pharmacol."},{"key":"45354_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/0019-5154.110832","volume":"58","author":"MK Church","year":"2013","unstructured":"Church, M. K. & Church, D. S. Pharmacology of antihistamines. Indian J. Dermatol. 58, 219\u2013224. https:\/\/doi.org\/10.4103\/0019-5154.110832 (2013).","journal-title":"Indian J. Dermatol."},{"key":"45354_CR32","doi-asserted-by":"publisher","first-page":"13316","DOI":"10.1073\/pnas.93.23.13316","volume":"93","author":"I Inoue","year":"1996","unstructured":"Inoue, I. et al. Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. Proc. Natl. Acad. Sci. U. S. A. 93, 13316\u201313320. https:\/\/doi.org\/10.1073\/pnas.93.23.13316 (1996).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"45354_CR33","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1517\/13543784.2012.719872","volume":"21","author":"G Quesseveur","year":"2012","unstructured":"Quesseveur, G., Nguyen, H. T., Gardier, A. M. & Guiard, B. P. 5-HT2 ligands in the treatment of anxiety and depression. Expert Opin. Investig. Drugs 21, 1701\u20131725. https:\/\/doi.org\/10.1517\/13543784.2012.719872 (2012).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"45354_CR34","doi-asserted-by":"publisher","first-page":"114674","DOI":"10.1016\/j.bbr.2023.114674","volume":"455","author":"HL Robinson","year":"2023","unstructured":"Robinson, H. L., Nicholson, K. L., Shelton, K. L., Hamilton, P. J. & Banks, M. L. Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase: Cre male and female rats. Behav. Brain Res. 455, 114674. https:\/\/doi.org\/10.1016\/j.bbr.2023.114674 (2023).","journal-title":"Behav. Brain Res."},{"key":"45354_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.apsb.2023.12.005","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Targeting cAMP in D1-MSNs in the nucleus accumbens, a new rapid antidepressant strategy. Acta Pharm. Sin. B 14, 667\u2013681. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.005 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"45354_CR36","doi-asserted-by":"publisher","first-page":"113744","DOI":"10.1016\/j.expneurol.2021.113744","volume":"342","author":"D Zhao","year":"2021","unstructured":"Zhao, D. et al. The paraventricular thalamus input to central amygdala controls depression-related behaviors. Exp. Neurol. 342, 113744. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113744 (2021).","journal-title":"Exp. Neurol."},{"key":"45354_CR37","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1007\/s00429-017-1445-8","volume":"222","author":"X Dong","year":"2017","unstructured":"Dong, X., Li, S. & Kirouac, G. J. Collateralization of projections from the paraventricular nucleus of the thalamus to the nucleus accumbens, bed nucleus of the stria terminalis, and central nucleus of the amygdala. Brain Struct. Funct. 222, 3927\u20133943. https:\/\/doi.org\/10.1007\/s00429-017-1445-8 (2017).","journal-title":"Brain Struct. Funct."},{"key":"45354_CR38","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1073\/pnas.0700293104","volume":"104","author":"BN Armbruster","year":"2007","unstructured":"Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S. & Roth, B. L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. U. S. A. 104, 5163\u20135168. https:\/\/doi.org\/10.1073\/pnas.0700293104 (2007).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"45354_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev-neuro-071013-014048","volume":"37","author":"SM Sternson","year":"2014","unstructured":"Sternson, S. M. & Roth, B. L. Chemogenetic tools to interrogate brain functions. Annu. Rev. Neurosci. 37, 387\u2013407. https:\/\/doi.org\/10.1146\/annurev-neuro-071013-014048 (2014).","journal-title":"Annu. Rev. Neurosci."},{"key":"45354_CR40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nature08002","volume":"459","author":"JA Cardin","year":"2009","unstructured":"Cardin, J. A. et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459, 663\u2013667. https:\/\/doi.org\/10.1038\/nature08002 (2009).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45354-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45354-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45354-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:38:56Z","timestamp":1779349136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45354-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45354"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45354-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.K., D.T., F.S, H.M., H.Y., and Taro K. were employees of Sumitomo Pharma Co., Ltd., Osaka, Japan, when this study was conducted. M.S-K. and Tadafumi K. received research grants from Sumitomo Pharma Co., Ltd. during the conduct of this study. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15779"}}